Predicting recurrence of meningioma using DNA methylation for clinical practice.
作者信息
Groff Karenna J, Snuderl Matija
机构信息
Division of Neuropathology, Department of Pathology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
出版信息
Neuro Oncol. 2025 May 15;27(4):1017-1018. doi: 10.1093/neuonc/noaf003.
Abstract
摘要
相似文献
1
Predicting recurrence of meningioma using DNA methylation for clinical practice.利用DNA甲基化预测脑膜瘤复发用于临床实践。
Neuro Oncol. 2025 May 15;27(4):1017-1018. doi: 10.1093/neuonc/noaf003.
2
Establishment of a patient-derived 3D in vitro meningioma model in xeno-free hydrogel for clinical applications.在无动物源水凝胶中建立用于临床应用的患者来源的三维体外脑膜瘤模型。
Acta Neuropathol Commun. 2025 Apr 24;13(1):81. doi: 10.1186/s40478-025-02008-w.
3
Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival.MIB-1指数在脑膜瘤中的预后价值：一项回顾性队列研究以确定复发和生存的最佳临界值
J Neurooncol. 2025 May 12. doi: 10.1007/s11060-025-05057-2.
4
Is DNA Methylation a Ray of Sunshine in Predicting Meningioma Prognosis?DNA甲基化能否成为预测脑膜瘤预后的一线曙光？
Front Oncol. 2020 Sep 4;10:1323. doi: 10.3389/fonc.2020.01323. eCollection 2020.
5
Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: A multicenter prospective study.脑膜瘤基于DNA甲基化的复发预测指标的验证及新一代更新：一项多中心前瞻性研究
Neuro Oncol. 2025 May 15;27(4):1004-1016. doi: 10.1093/neuonc/noae236.
6
[A two-site combined prediction model based on HOXA9 DNA methylation for early screening of risks of meningioma progression].基于HOXA9 DNA甲基化的双位点联合预测模型用于脑膜瘤进展风险的早期筛查
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Nov 20;44(11):2110-2120. doi: 10.12122/j.issn.1673-4254.2024.11.07.
7
The Emerging Relevance of H3K27 Trimethylation Loss in Meningioma: A Systematic Review of Recurrence and Overall Survival with Meta-Analysis.H3K27 三甲基化缺失在脑膜瘤中的新作用：复发和总体生存的系统评价及荟萃分析。
World Neurosurg. 2022 Jul;163:87-95.e1. doi: 10.1016/j.wneu.2022.04.048. Epub 2022 Apr 16.
8
Preoperative Assessment of Meningioma Consistency Using a Combination of MR Elastography and DTI.使用磁共振弹性成像和 DTI 组合对脑膜瘤一致性进行术前评估。
AJNR Am J Neuroradiol. 2024 Nov 7;45(11):1755-1761. doi: 10.3174/ajnr.A8385.
9
Development and validation of a molecular classifier of meningiomas.脑膜瘤分子分类器的开发与验证
Neuro Oncol. 2025 Jun 21;27(5):1258-1269. doi: 10.1093/neuonc/noae242.
10
Performance of Radiomics-based machine learning and deep learning-based methods in the prediction of tumor grade in meningioma: a systematic review and meta-analysis.基于影像组学的机器学习和深度学习方法在预测脑膜瘤肿瘤分级中的性能：一项系统综述和荟萃分析
Neurosurg Rev. 2025 Jan 24;48(1):78. doi: 10.1007/s10143-025-03236-3.
本文引用的文献
1
Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: A multicenter prospective study.脑膜瘤基于DNA甲基化的复发预测指标的验证及新一代更新：一项多中心前瞻性研究
Neuro Oncol. 2025 May 15;27(4):1004-1016. doi: 10.1093/neuonc/noae236.
2
Grading meningioma resections: the Simpson classification and beyond.脑膜瘤切除术分级：辛普森分类法及其他方法。
Acta Neurochir (Wien). 2024 Jan 23;166(1):28. doi: 10.1007/s00701-024-05910-9.
3
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.全基因组DNA甲基化谱作为中枢神经系统肿瘤主要分子诊断检测方法的临床应用——一项前瞻性研究及临床检测指南
Neurooncol Adv. 2023 Jun 26;5(1):vdad076. doi: 10.1093/noajnl/vdad076. eCollection 2023 Jan-Dec.
4
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.脑膜瘤 DNA 甲基化组鉴定出生物学驱动因素和治疗脆弱性。
Nat Genet. 2022 May;54(5):649-659. doi: 10.1038/s41588-022-01061-8. Epub 2022 May 9.
5
A clinically applicable integrative molecular classification of meningiomas.一种具有临床应用价值的脑膜瘤综合分子分类方法。
Nature. 2021 Sep;597(7874):119-125. doi: 10.1038/s41586-021-03850-3. Epub 2021 Aug 25.
6
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.DNA 甲基化分析预测脑膜瘤复发风险：建立并验证列线图以优化临床管理。
Neuro Oncol. 2019 Jul 11;21(7):901-910. doi: 10.1093/neuonc/noz061.
7
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.基于 21 基因表达检测的乳腺癌辅助化疗。
N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.
8
DNA methylation-based classification of central nervous system tumours.基于 DNA 甲基化的中枢神经系统肿瘤分类。
Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14.
9
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.基于 DNA 甲基化的脑膜瘤分类和分级系统：一项多中心回顾性分析。
Lancet Oncol. 2017 May;18(5):682-694. doi: 10.1016/S1470-2045(17)30155-9. Epub 2017 Mar 15.
10
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.利用高密度DNA甲基化阵列对少量存档肿瘤材料中的髓母细胞瘤进行稳健的分子亚组分析和拷贝数分析。
Acta Neuropathol. 2013 Jun;125(6):913-6. doi: 10.1007/s00401-013-1126-5. Epub 2013 May 14.
Zotero 插件